Natrogen Therapeutics

About:

Natrogen Therapeutics develops Natura-alpha, a small molecule oral compound used in clinical trials for patients with ulcerative colitis.

Website: http://natrogen.com

Description:

Natrogen Therapeutics International, Inc. was incorporated in 2002 and is based in New York, New York.

Total Funding Amount:

$1.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2002-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2010-04-05

IPO Status:

Private

Industries: